Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma
Clinical trial NCT03347279 · COMPLETED
Trial details
- NCT number
- NCT03347279
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-23
- Primary completion
- 2020-09-08
- Enrollment
- 1061
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.